Cephalexin, a New Orally Absorbed Cephalosporin Antibiotic
AUTOR(ES)
Wick, Warren E.
RESUMO
A new antibiotic, structurally related to cephaloglycin, has been assigned the generic name cephalexin, 7-(D-α-amino-α-phenylacetamido)-3-methyl-3-cephem-5-carboxylic acid. In vitro antimicrobial activity of cephalexin does not equal that of cephaloglycin. However, excellent oral absorption and lack of serum binding of cephalexin compensates significantly for the lower in vitro activity. Exceptional efficacy against experimental bacterial infections in mice was obtained with cephalexin therapy as compared with cephaloglycin, tetracycline, and chloramphenicol. The data suggest that cephalexin merits clinical trial.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=547059Documentos Relacionados
- In Vitro Antimicrobial Activity and Human Pharmacology of Cephalexin, a New Orally Absorbed Cephalosporin C Antibiotic
- In Vitro Activity of Cefaclor, a New Orally Administered Cephalosporin Antibiotic
- Antibacterial Activity of Cefamandole, a New Cephalosporin Antibiotic, Compared with that of Cephaloridine, Cephalothin, and Cephalexin
- Bacampicillin: a New Orally Well-Absorbed Derivative of Ampicillin
- Evaluation of Cefazolin, a New Cephalosporin Antibiotic
